期刊文献+

如意金黄散外敷联合地特胰岛素治疗糖尿病足32例疗效观察 被引量:1

Clinical Effect Observation of External Application of Wishful Golden Power combined Insulin Detemir for Treatment of 32 Cases of Diabetic Foot
下载PDF
导出
摘要 目的:讨论如意金黄散联合地特胰岛素治疗糖尿病足的临床疗效与影响。方法:选取我院已确诊32例糖尿病足患者并分为A、B两组。A组16例患者使用如意金黄散外敷联合地特胰岛素进行治疗。B组16例患者使用一般药物进行治疗。将治疗总有效率以及治愈时间等指标进行比较。结果:治疗后总有效率显示,A组治疗总有效率100%,显著高于B组56.2%;两组治疗时间比较显示,A组平均治疗时间显著少于B组(P<0.05)。结论:如意金黄散外敷联合地特胰岛素治疗糖尿病足能够减少治疗时间,降低治疗费用。两种药物联合使用能够对糖尿病足病情发展起到控制作用,降低疾病致残率。 Objective: To discuss the clinical effect and impact of wishful golden powder combined insulin detemir for treatment of diabetic foot. Method: 32 patients with diagnosed diabetic foot were chosen and divided into A and B group. 16 patients of A group were given external application of wishful golden powder combined insulin detemir for treatment while 16 patients of B group were given common medicine for treatment. Indicators like total effective rate and healing time of the 2 groups were compared. Result: Total effective rate of A group wast 100% obviously higher than B group 56.2%; average healing time of A group was obviously shorter than B group (P〈O.05). Conclusion: External application of wishful golden powder combined insulin detemir for treatment of diabetic foot can shorten healing time and reduce treatment expense. Combined application of the 2 kinds of drugs can control the progress of the diseases and lower disability rate.
作者 谢翊 李填新
出处 《内蒙古中医药》 2014年第17期92-93,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 如意金黄散外敷 地特胰岛素 糖尿病足 疗效 Wishful Golden Powder Insulin Detemir Diabetic Foot Clinical Effect
  • 相关文献

参考文献5

二级参考文献31

  • 1陆菊明.地特胰岛素的临床实践:PREDICTIVE研究结果分析[J].中华糖尿病杂志,2010,2(1). 被引量:5
  • 2王玉珍,许樟荣.第五届国际血管外科暨第一届国际糖尿病血管疾病会议(糖尿病足部分)纪要[J].中华糖尿病杂志(1006-6187),2005,13(2):152-153. 被引量:184
  • 3Singh N,Armstrong DG,Lipsky BA.Preventing foot ulcers in patients with diabetes[J].JAMA,2005,293(2):217-228.
  • 4Arora S,Pomposelli F,LoGerfo FW,et al.Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization[J].J Vasc Surg,2002,35(3):501-505.
  • 5Veves A,Akbari CM,Primavera J,et al.Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy,vascular disease and foot ulceration[J].Diabetes,1998,47(3):457-463.
  • 6Reiber GE,Vileikyte L,Boyko EJ,et al.Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings[J].Diabetes Care,1999,22(1):157-162.
  • 7Eonds M,Foster A.The use of antibiotics in the diabetic foot[J].Am J Surg,2004,187(5A):25-28.
  • 8Andrew JM,Robert S,Loretta V.Neuropathic Diabetic Foot Ulcers[J].N Engl J Med,2004,351(1):1694-1695.
  • 9Eneroth M,Apelqvist J,Stenstrom A.Clinical characteristics and outcome in 223 diabetic patients with deep foot infections[J].Foot Ankle Int,1997,18(11):716-722.
  • 10Samson O,Edward B,Hienvu C,et al.A Comparison of Two Diabetic Foot Ulcer Classification Systems[J].Diabetes Care,2001,24(1):84-88.

共引文献110

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部